Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study)

• Main Authors: Gholamreza Toogeh (Author), Hassan Abolghasemi (Author), Peyman Eshghi (Author), Mohammadreza Managhchi (Author), Mohammadreza Shaverdi-niasari (Author), Katayoon Karimi (Author), Samin Roostaei (Author), Neda Emran (Author), Alireza Abdollahi (Author)
• Format: Bog
• Udgivet: Iranian Society of Pathology, 2016-07-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

Background: Recombinant activated factor VII induces hemostasis in patients with coagulopathy disorders. AryoSeven™ as a safe Iranian Recombinant activated factor VII has been available on our market. This study was performed to establish the safety of AryoSeven on patients with coagulopathy disorde...